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The palliative care needs and experiences of 
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Abstract
Background: The palliative care needs of people with advanced head and neck cancer pose unique complexities due to the impact 
the illness has on eating, speaking, appearance and breathing. Examining these needs would help provide guidance about developing 
relevant models of care and identify gaps in research knowledge.
Aim: To identify and map out the palliative care needs and experiences for people with advanced head and neck cancer.
Design: A scoping literature review following the methods described by the Joanna Briggs Institute.
Data sources: An electronic search of the literature was undertaken in MEDLINE (Ovid), EMBASE and CINAHL covering the years 
January 1996 to January 2019.
Results: People with advanced head and neck cancer often had palliative care needs but there was variability in the timing and 
access to relevant services. A high prevalence of interventions, for example hospital admissions were needed even during the 
last month of life. This was not necessarily negated with early engagement of palliative care. Dissonance between patients and 
family carers about information needs and decision-making was an additional complexity. Studies tended to be descriptive in 
nature, and often involved a single centre.
Conclusion: This scoping review demonstrates the complexity of care for people with advanced head and neck cancer and the issues 
related to the current healthcare systems. Focus on appropriate referral criteria, increased integration and coordination of care 
and robust evaluation of specific care components seems key. Linkage between research and service design delivery across teams, 
disciplines and care settings seems pertinent.
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Introduction
On a global scale, head and neck cancer is the sixth most 
common cancer,1 representing a wide-ranging group of 
cancers arising from the epithelial lining of the upper 
aerodigestive track, and affecting the oral cavity includ-
ing the lips; pharynx; larynx; paranasal sinuses and nasal 
cavity; salivary glands and middle ear. Within certain 
parts of the world, for example the United Kingdom 
(UK), the incidence of head and neck cancer is expected 
to rise by 50% over the next 20 years. This trend is attrib-
uted to more cases caused by Human Papilloma Virus 
(HPV).2 Although there is variability depending on the 
underlying histology, the overall 5-year survival rate has 
remained at 40% to 65%,3 due to factors such as 
advanced stage disease presentation and co-morbidi-
ties. Additionally, one in every five people with head and 
neck cancer will die within 12 months following diagno-
sis.4 Worldwide, poverty and socio-economic depriva-
tion impact on survival, raising concerns about 
inequalities or disparities in access to healthcare ser-
vices, including palliative care provision.5,6
Compared with other cancers, the palliative care needs 
of people with advanced head and neck cancer pose 
unique complexities due to the impact the illness has on 
eating, speaking and breathing.7–9 Head and neck cancer 
can be very visible, often causing facial disfigurement10 
and distorted or unintelligible speech. Patients have dis-
tinct care challenges and can require feeding tubes and 
tracheostomies to support their vital functions. Symptoms 
can cause significant psychological distress and social iso-
lation and there is a higher risk of suicide compared with 
the general cancer population.11 Earlier in the disease tra-
jectory, family carers to those with head and neck cancer 
also report distress and unmet needs.12,13
Given the overall prognosis and potential for rapid 
demise for a significant proportion of head and neck can-
cer patients, it is important to consider support at the 
time of diagnosis for those with advanced disease. 
Understanding the palliative care needs and experiences 
of this vulnerable population is important to help devise 
relevant models of care and identify future research gaps. 
Although there have been two systematic reviews on 
unmet needs for advanced cancer patients,14,15 none have 
specifically focused on people with advanced head and 
neck cancer. Head and neck cancer brings unique chal-
lenges due to the anatomical location of the illness, and 
the fact patients are likely to experience significant symp-
tom (physical and psychological) and healthcare burden 
regardless of what treatment course is chosen.16 A scop-
ing review is beneficial to examine broad areas and is par-
ticularly useful to report on the types of evidence which 
may inform practice or identify key gaps in the evidence.17 
The aim of this scoping review was to examine and map 
the palliative care needs and experiences for people with 
advanced head and neck cancer. As the research objective 
was wide-ranging, and the identified study designs were 
expected to be heterogeneous, a scoping review approach 
What is already known about the topic?
•• Advanced head and neck cancer patients have specific challenges due to the impact of the illness on vital func-
tions such as eating, speaking and breathing.
•• Identifying the palliative care needs of this specific cancer subgroup would help provide guidance about how 
services could best provide care.
What this paper adds?
•• Advanced head and neck cancer patients have a diverse range of palliative care needs, but there is variability in 
terms of access and timing to palliative care services.
•• Dissonance between patients and family carers about information needs and decision-making represent addi-
tional complexities.
•• Head and neck cancer patients frequently require acute interventions even during the last weeks of their life.
Implications for practice, theory or policy
•• Tailored needs-based referral systems for advanced head and neck cancer patients may help address issues relat-
ing to access to palliative care services.
•• Models of care focused on increased integration and coordination across different care settings and multi-
disciplinary teams may help address issues relating to frequent use of acute interventions during the last 
weeks of life.
•• Prospective multi-centre studies, potentially using mixed methods approaches, and focused on testing spe-
cific components of care may help further understand and tailor services more appropriately to meet needs.
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The specific question to be addressed was:
What types of palliative care needs and challenges have 
been reported by people with advanced head and neck 
cancer, their family carers, and the healthcare professionals 
looking after them, in terms of their experiences and usage 
of healthcare services?
Design
The Joanna Briggs Institute Scoping Review framework 
was used to guide conduct of the review.17 This frame-
work represents well-established, detailed guidance, 
has previously been used to assess the quality of scop-
ing reviews,18 and helped, in part, frame the develop-
ment of the PRISMA extension on the reporting of 
scoping reviews.19
Search strategy
An electronic search of the literature was undertaken in 
MEDLINE (Ovid), EMBASE and CINAHL covering the years 
January 1996 to January 2019. It was undertaken using 
keywords and subject heading terms for ‘Palliative care’ 
and ‘head and neck neoplasms’ (Textbox 1) using speci-
fied inclusion and exclusion criteria (Textbox 2). The 
searches were initially run on 12th April 2017 and further 
updated on 8th February 2019. The full MEDLINE search is 
available in Supplemental Table 1 and the other searches 
are available on request of the corresponding author. 
Titles and abstracts were initially screened (CRM, QMH or 
MC) to identify potentially eligible papers and any areas of 
uncertainty were resolved by another reviewer (PD). The 
full manuscripts of potentially eligible papers were fur-
ther independently screened against eligibility criteria by 
two reviewers (either CRM and PP, CRM and PC, HCD and 
PD), with a third reviewer (PD or CRM dependent on the 
team) resolving any conflicts of opinion, to determine a 
definitive list of included studies (Figure 1). No additional 
hand searching was conducted but references of the 
included papers were also screened for any other relevant 
papers that might have been missed by the search.
Data extraction
Data was extracted using a specially designed proforma 
by one member of the research team (CRM, PP, PC or PD) 
and 75% were checked by a second reviewer (CRM or PD). 
Data was mapped out in a descriptive manner according 
to the following: setting, country, population characteris-
tics, study design, intervention (where appropriate) and 
findings. The World Health Organisation’s definition of 
palliative care includes the ‘early identification and impec-
cable assessment and treatment of pain and other prob-
lems, physical, psychosocial and spiritual’.20 Therefore, 
prior to the search, the team had agreed key themes 
within the protocol based on the expert knowledge within 
the team, and anticipating the likely complexities relating 
to communication and need for interventions to support 
vital functions of relevance to people with head and neck 
cancer. These themes were: symptom control; psychologi-
cal well-being; communication and/or decision-making; 
Textbox 1. Search terms used for scoping literature review.
Head and neck cancer
1. exp Oropharyngeal Neoplasms/
2. ‘Head and Neck Neoplasms’/
3. exp Otorhinolaryngologic Neoplasms/
4. exp Neoplasms/
5.  (cancer* or carcinoma* or neoplas* or tumor* or tumour* 
or malignan* or SCC).tw.
6. 4 or 5
7. exp Oropharynx/
8.  (oropharyn* or mesopharyn* or tonsil* or (head adj3 neck) 
or ‘tongue base’).tw.
9. 7 or 8
10. 6 and 9
11. (HNSCC or SCCHN or OP-SCC or OPSCC).tw.
12. 1 or 2 or 3 or 10 or 11
Palliative care
13. exp Palliative Care/
14. exp Terminal Care/
15. exp Terminally Ill/
16.  palliat*.mp. [mp=title, original title, abstract, name of 
substance word, subject heading word, unique identifier]
17. 1 or 2 or 3 or 4
18. 12 and 17
Textbox 2. Inclusion and exclusion criteria.
Inclusion criteria
•  Empirical research studies (any research design) of 
palliative care needs and experiences
•  Involving people with advanced head and neck cancer, 
or family carers of adults with advanced head and neck 
cancer, or healthcare professionals supporting adults with 
advanced head and neck cancer
•  Within any healthcare setting and any country
•  Published in English
*Advanced head and neck cancer defined as involving those 
with incurable disease and/or being treated with palliative 
intent
Exclusion criteria
•  Any studies where the primary focus involves children 
(⩽18 years old); patients who have solely undergone 
curative treatment; or survivorship issues
•  Case reports, case series, opinion pieces or letters
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place of care and death and medical interventions at the 
end-of-life.
Data analysis
Following the data extraction, the studies were catego-
rised to one or more of these themes based on their 
findings, and the themes revised accordingly, following 
review and discussion by members of the team (CRM 
and PD). Following this, the data was tabulated and syn-
thesised within each of the final themes. The final 
themes agreed were:
•• overall palliative care need and access to palliative 
care services
•• physical symptoms
•• psychosocial and spiritual well-being
•• medical interventions in the last 12 months of life
•• communication and decision making
•• place of death.
Due to the wide range of different study methodolo-
gies, and in keeping with the accepted remit of scoping 
review guidance, specific quality appraisal was not con-
ducted.17 Instead, key study limitations, where docu-
mented within the manuscripts, were extracted to inform 
the synthesis of data within themes.
Results
Range of studies
From 1278 initial records, 185 papers were screened for 
eligibility, of which 46 were included in the full review. An 
overview of the characteristics of these 46 included stud-
ies is provided in Supplemental Table 1.
Studies were most commonly conducted in Europe 
(n = 23)8,22,23,29,31–33,35,37,43–45,47–49,51,52,55,57,59,63–65 with 12 
being conducted in Asia,24–28,34,40,42,45,53,61,62 nine in North 
America,30,36,38,39,41,50,54,57,58one in Saudi Arabia21 and one in 
Australia.60 Quantitative methods were used for the majority 
of the studies (n = 41) with four using qualitative meth-
ods29,36,52,65 and one study utilising mixed methods.59 All the 
quantitative studies were descriptive or observational in 
nature (cross-sectional survey, case-control, or cohort stud-
ies). Ten studies were nation-wide studies25–27,30,37,40,47,50,61,62,65 
and four were based within a specific region.39,49,64 The 
remaining 32 studies were conducted within single institu-
tions. Thirty-six studies focused purely on patie
nts,21–28,30–41,45–50,53–55,57,59–64 two on family carers alone,44,58 
and two on healthcare professionals alone.43,65 A further four 
focused on both patients and family carers,8,42,51,52 and two 
on patients and healthcare professionals.29,56
For each key area, studies are presented in Tables 1 to 
6; studies which have findings about more than one key 
area are reported separately within the different tables.
Overall palliative care need and access to 
palliative care services
There were 11 studies reporting on these areas (Table 1). 
Studies suggest that 18% to 21% of all people with head and 
neck cancer received palliative management following 
diagnosis,56,63 with a higher rate seen for those residing in 
more deprived areas.57 There was some evidence that access 
may be lower than need, however, with one study estimat-
ing 28.3% of hospital in-patients had relevant needs.23
Head and neck cancer patients were more likely to 
receive palliative care or prompt a referral to palliative 
care services than other cancer patients38,39,41,62 due to 
the high degree of symptom burden.64 Timing of referral 
to palliative care teams varied, with two studies suggest-
ing that head and neck cancer patients were referred 
early,39,41 and one study observing late referral, that is, in 
the last 30 days of life.30 Higher rates of access to palliative 
care services were observed among those with HNC who 
were older, white and female.30,50
Patients’ physical symptoms
Nineteen studies included a focus on this area (Table 2). 
Patients reported a diverse range of symptoms8,32,54 with 
the most recent study reporting patients had an average 
of 10 somatic symptoms.8 Pain was commonly reported 
(prevalence ranging from 40% to 95%)8,24,31–33,42,45,54,57 and 
one study described it being worse for those with more 
advanced disease.34 Pain could be complex in nature, 
require multiple medications including the frequent use 
of opioids.24,31,35,42,48 Fatigue or lack of energy (preva-
lence ranging from 77% to 81%) and weight loss were 
also frequently reported.8,45,46,54,57 Other symptoms were 
wide-ranging including difficulty eating or swallowing, 
dry mouth, incontinence, bleeding, dyspnoea, fungating 
lesions, change in appetite, cough, communication 
difficulties, constipation, retained mucus and 
insomnia.8,22,31,32,33,42,45,46,54,57,61 One study described the 
intensity of nursing care needed to support patients, in 
part due to symptom control.59 Patients’ concerns about 
adequate symptom control were perceived as a barrier to 
whether or not they would be able to die at home.52
From the family carers’ viewpoint, pain, inability to eat 
and tumour fungation were reported to be the most dis-
tressing symptoms.42 Bereaved relatives perceived there 
was scope to improve on symptom management,58 a view 
shared by General Practitioners. In one study, only 45% 
General Practitioners perceived their patients had been 
satisfied with the level of symptom control.43
Patient’s psychosocial and spiritual well-
being
Sixteen studies included a focus on this area (Table 3). 











Table 1. Overall palliative care needs and access to palliative care services for advanced head and neck cancer patients.
Study Aim Main findings Reported limitations
Overall palliative care needs
Becker et al.23 Identify percentage of cancer patients with palliative care needs 
(PCN)
PCN prevalence highest in HNC patients (135/477, 28.3%) compared with other cancer groups 
(as defined by WHO definition and assessed by treating physician)
Single-centre analysis
Challenging to define PCN
Rylands et al.57 Report treatment selection, survival, health-related quality of 
life, cause and place of death in relation to deprivation status
246/523 (47%) resided in the ‘most deprived’ IMD quartile
37/67 (55%) of those receiving palliative treatments lived in ‘most deprived’ IMD quartile
Those in more deprived areas reported more social-emotional dysfunction and worse overall 
quality of life (levels of physical functioning were similar)
Not specifically reported
Shah et al.60 Estimate frequency of referral of HNC patients to ‘terminal care’
Ascertain where and when the patient died
74 (18%) patients were referred for palliative management
Mean survival 5.5 months
Overall 1-year survival = 11% of the cohort (n = 8 patients)
Small numbers
Short duration




Assess group of incurable HNC patients presenting for the first 
time to one surgeon
Emphasis on natural history and palliative therapy required
60/286 patients (21%) deemed appropriate for palliative care following initial diagnosis
Reason included advanced disease (n = 39), poor medical condition (n = 13) and patient refusal 
of curative treatment (n = 8)
Palliative treatment included operative interventions (n = 22, 37%), tracheostomy (n = 10), PEG 
insertion (n = 14); 26 patients (43%) had palliative radiotherapy
Not specifically reported
Access to palliative care services
Enomoto et al.30 Compare monthly Medicare costs for all services used during 
last 12 months of life by HNC patients – comparing those who 
received hospice care with those who did not
Most patients were enrolled in hospice care within 30 days of death (63.4% for oral cancer; 
57.8% for pharyngeal cancer).
Mean cost for patients enrolled in hospice was >$7000 less compared with those who weren’t
Female gender, white race, being married and increasing year of diagnosis were significantly 
associated with higher hospice use
Other health outcomes not included for 
example, QoL, patient satisfaction
Didn’t include unpaid carer costs
Hui et al.38 Determine proportion and predictors of cancer patients who 
receive palliative care (PC)
Multi-variate analysis showed older age, being married, and specific cancer types for example 
gynaecological, lung, HNC were significantly associated with PC referral (although OR 1.01 for 
HNC, 95% CI 0.53–1.96)
Time between PC consultation and death was 2 months for HNC patients
Retrospective nature
Didn’t include clinical outcomes, for 
example, QoL
Patient may have been offered but 
declined PC consult
Johnstone et al.39 Assess whether Nova Scotia cancer patients (who may need 
palliative care) are being referred to the comprehensive Halifax-
based Palliative Care Program (PCP)
PCP referral was more likely for those who died with HNC (OR 5.4, 95% CI 3.0–9.7)
HNC was less likely to be a predictor of late PCP referral
Not specifically reported
Kwon et al.41 Define characteristics, outcomes and utilisation of medical 
services by cancer patients referred early in their disease course 
to outpatient palliative care services
Early referrals (ERs) = those who were receiving or had completed treatment with curative 
intent or had an expected survival time of more than 2 years. 
From all referrals, 73/200 (37%) had HNC
The most common tumour type for ERs was HNC (67%)
Logistic regression analysis showed having HNC was an independent predictor for early 
referral to palliative care service (OR 9.5, CI 3.09–27.08, p < 0.0001)
Population selected based on first 
referral to Supportive Care Centre rather 
than prognosis/symptom distress
Mulvey et al.50 Determine incidence of palliative care consultations (PCC) among 
hospitalised metastatic, incurable HNC patients
Examine relationship between palliative care encounters and in-
hospital morbidity, mortality, length of hospitalisation and costs
PCC was documented in 4029 cases (5%)
PCC significantly associated with age >80 years; female gender; self-pay payor status 
(uninsured); and prior radiation
PCC significantly less likely for those with Medicare/Medicaid; receiving chemotherapy (OR 
0.27, p < 0.001) or radiation (OR 0.60; p = 0.037) during admission
PCC associated with reduced hospital-related costs but not length of hospital stay
Analysis of long-term outcomes not 
possible
Certain costs for example, physician-
related costs not included in database
Unable to determine if PCC was provided 
by certified palliative care physician
Tang et al.62 Evaluate associations between hospice utilisation in the last 
year of life and patient demographics, disease characteristics, 
physician specialty, hospital characteristics and availability of 
healthcare resources at the hospital and regional levels in Taiwan
HNC patients (along with those with breast, liver, pancreatic or bile duct and gastric cancer) 
more likely to use hospice services compared with lung cancer patients (OR 1.06, 95% CI 
1.01–1.10)
Observational study – potential impact 
of unmeasured factors for example, 
patient attitudes towards end-of-life 
care
Ullgren et al.64 Describe HNC patients referred to palliative care and how care 
transition from acute oncological to palliative care impacted on 
Health Related Quality of Life (HRQoL) and information
Explore HNC patients’ HRQoL and perceived information
43/202 (21%) patients had been referred to palliative care
Those referred were more likely to have undergone multi-modal treatment; have lower levels 
of global health and higher symptom burden (fatigue, pain, nausea, vomiting) compared with 
those without palliative care referral
Those referred reported they had visited ED more frequently compared to group without 
palliative care (18/43, 43% vs 22/114, 19%)
Those referred to palliative care had lower levels of perceived information about causes of 
disease, extent/spread of disease compared with those without palliative care referral
Small proportion referred to palliative 
care
Didn’t use HNC specific instruments

















Table 2. Physical symptoms in advanced head and neck cancer patients.
Study Aim Main findings Reported limitations
Physical symptoms in advanced head and neck cancer
Alt-Epping 
et al.22
Assess symptoms and psychosocial needs of 
patients with incurable HNC
Mean QoL 87.7/148 for 22 patients – using Functional Assessment of Chronic Illness Therapy Head 
and Neck Module (FACT-H&N), 0 = worst, 148 = best QoL
Being unable to eat the favoured foods; being able to eat solid foods; suffering from a dry mouth 
were almost uniformly present
Small numbers
Questionnaires not fully understood by 
participants
Bisht et al.24 Examine effect of palliative drug therapy on QoL 
in advanced HNC patients
Pain most frequent symptom (in 38/40, 95% patients); frequent polypharmacotherapy (mean 8.7 
drugs)
Improvement in QoL – baseline mean score 950.39 versus 1336.67 at 1 month and 1405.49 at 
2 months (range 0–2800) after using palliative drug therapy
Small numbers
Short duration of follow-up
QoL measure not specific for HNC
Forbes32 Outline nature, incidence and management 
of problems and the role of the hospice in the 
patients care
Patients had a median of 6 symptoms (range 2–12)
28 (74%) patients had dysphagia and difficulty feeding
30 (79%) had weight loss or pain; strong opioids were prescribed for 13 (34%)
18 (47%) had bleeding from a wound and/or tracheostomy
20 (53%) had a tracheostomy, 8 had a NGT and 1 had a PEG
Not specifically reported
Gupta et al.34 Measure QoL in upper aerodigestive tract cancer 
(UADT) cancer patients in comparison with 
hospital controls
Mean composite QoL score for cases was poorer at 62.85/100 compared with 89.14/100 for 
controls; patients with oropharynx and hypopharynx cancer had worst mean scores across all 
domains
Stage IV disease had worst mean score for pain, appearance, activity and recreation
Stage III disease had worst mean score for swallowing, chewing, speech, mood and anxiety
Not specifically reported
Heinonen et al.35 Describe current status of palliative care of HNC 
patients in one specific university hospital region
From 60 HNC patients, 45% had a PEG and 28% had a tracheostomy




Symptoms not systematically reported
Lal et al.42 Evaluate range of symptoms, other needs and 
evaluation of treatment strategies, especially for 
pain management
Pain most common symptom (134/153, 87%), then fungating lesion (47/153, 31%) and difficult/
painful swallowing (61/153, 40%)
Median duration of symptoms was 4 months (range 1–48 months)
103/134 (77%) had mixed nociceptive and neuropathic pain; 95/134 (71%) had moderate/severe 
pain and needed opioids
101/134 (65%) needed NGT feeding; 80 (52%) had on-going weight loss
Retrospective nature
Ledeboer et al.43 Evaluate experience of GPs in the care of 
palliative HNC patients, experiences of 
communication and consultation of attending 
specialists
Only 45% GPs perceived their patients were satisfied with their symptom control Retrospective nature
Views of GPs (rather than patients)
Lidstone et al.45 Assess prevalence and severity of symptoms 
and concerns – identify patient groups who 
might benefit from routine SPC involvement in 
outpatient clinics
HNC patients reported highest prevalence of mouth and taste problems (38/60, 63%), and 
swallowing problems (30/60, 50%)
31/60 (52%) HNC patients had pain and 26/60 (43%) reported change in appetite
46/60 (77%) had a lack energy
Not specifically reported
Lin et al.46 Describe symptom patterns of terminal HNC 
patients in palliative care unit
Most common symptom was weight loss (97.9%); then pain (96.8%), cough (95.7%), dysphagia 
(90.4%), feeding difficulties (89.4%) and communication difficulties (78.7%)
33/94 patients had tracheostomy
Median equivalent morphine dose at admission was 70 mg/day (range 0–1080) and 160 mg/day 
(range 0–1600) immediately prior to death
Not specifically reported
Lokker et al.8 Determine prevalence and impact of symptoms 
on daily functioning in HNC patients during 
palliative phase
Examine discrepancies between patients and 
family members symptom scoring
HNC patients reported an average of 14 symptoms (range 0–26) of which 10 were somatic 
symptoms
Fatigue had highest prevalence (81%), then pain (75%), weakness (75%), trouble with short walks 
outside (65%) and dysphagia (59%).
Dyspnoea, voice changes, trouble with short walks outside and weakness had greatest impact on 
daily functioning
Perceptions about symptom impact on daily functioning differed between patients and their 
family members for ‘trouble with short walks’ and ‘difficulty sleeping’














Study Aim Main findings Reported limitations
Mercadante48 Establish degree of opioid sensitivity and possible 
factors involved in advanced stage HNC patients 
being followed up at home
Patients had mixed pain syndromes (23 somatic, 19 visceral, 19 neuropathic)
12/37 patients had good and 25/27 partial responsiveness to opioid
14/37 had steroids, 14/37 had anti-inflammatory drugs; amitriptyline and carbamazepine 
administered > 2 weeks in 8 and 11 patients respectively




Explore Irish HNC patient and care-givers views 
on EoL care
Concerns about symptom control perceived as a potential barrier to dying at home Some patients were in remission so views may 
alter as disease progresses
Price et al.54 Understand cause and location of death and 
symptoms experienced at the end of life
89/93 (94.7%) patients had at least one symptom in the 6 months prior to death
Most common symptom was pain, then dysphagia, anorexia/weight loss, fatigue/weakness and 
dyspnoea (mean of 4.7 symptoms per patient)
Retrospective nature
Small number
Roscoe et al.56 Understand ways in which end-stage HNC 
patients and their oncologists talk about end-of-
life issues
Patients overall QoL rated 7.29 (SD 2.81) on 0–10 scale (10 = excellent)
Most prevalent symptoms were pain, constipation, inability to use their mouth, dry mouth, mucus, 
weakness, fatigue, shortness of breath, anxiety, insomnia and speech problems
Small numbers
Single assessment rather than longitudinal
Shuman et al.58 Determine perceived quality of care for HNC 
patients at the end of their lives
Mean score for ‘management of symptoms’ = 31/100 (lowest mean score from all 9 assessed 
domains) as perceived by 58 bereaved family members
Poor response rate
Retrospective nature
Different environment for using validated tool
Shinozaki et al.61 Examine relationship between QoL and 
functional status in terminally ill HNC patients
No significant change in QoL between baseline and week 3 (using the European Organization for 
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-Core 15-Palliative 
Care (C15-PAL)
32 (44%) had a ‘tracheostoma’; 53 (74%) had enteral feeding
Median duration of hospital stay shorter for PEG-fed patients (21 days) compared with NGT-fed 
patients (64 days)
Fungating tumours requiring dressing changes in 22 (31%) patients; 5 (7%) patients had severe 
bleeding – 2 were fatal (2.8%)
Small numbers
Limited to in-patients only
Physical symptoms specifically in last 1–2 weeks of life
Ethunandan 
et al.31
Evaluate quality of dying experience by 
examining symptoms in the last week of life
27/32 (84%) had pain in week preceding death; 25/27 received opioids (18 given parentally)
20/32 had difficulty swallowing – 6 had a PEG and 1 had NGT (none inserted in last week life). 11 
had urinary incontinence and 3 had faecal incontinence
Bleeding was an issue in 5 patients
Retrospective nature
Fullarton et al33 Record characteristics, mode of death and 
potential indicators of the quality of care at the 
end of life for HNC patients
In last week of life, 33/76 (43%) patients had pain; 20/76 (26%) had dyspnoea




Limited number of hospice patients
Sesterhenn 
et al.59
Describe end-stage disease in advanced HNC 
patients – circumstances of final period of life 
and describe period in hospice setting
Intensive nursing support needed in hospice – 11/16 patients had tracheostomy; 13/16 received 
CAN (10 = PEG, 3 = NGT)
7/16 were incontinent rising to 12/16 in the two weeks prior to death
Not specifically reported
CAN: clinically-assisted nutrition; EoL: end of life; GPs: general practitioners; HNC: head and neck cancer; NGT: nasogastric tube; NOK: next-of-kin; PEG: percutaneous endoscopic gastrostomy; QoL: quality of life; SD: standard devia-


















Table 3. Psychosocial and spiritual well-being in advanced head and neck cancer patients.
Study Aim Main findings Reported limitations
Psychosocial and spiritual well-being in advanced head and neck cancer
Alt-Epping et al.22 Assess symptoms and psychosocial needs of patients with incurable 
HNC
12/22 (54.5%) patients reported distress levels of ⩾7/10 (using National Comprehensive 
Cancer Network distress thermometer)
Elevated level of depression and anxiety found in half the patients (6 and 5 patients, 
respectively)
Small numbers (n = 22)
Questionnaires not fully understood by participants
Gupta et al.34 Measure QoL in upper aerodigestive tract cancer (UADT) cancer 
patients in comparison with hospital controls
Assess impact of clinical predictors at time of diagnosis on QoL (using 
the University of Washington QoL questionnaire)
Most affected QoL domain was anxiety (cases mean score 21.6 versus controls 71.7, 0–100 
scale, where 100 – best symptom/function), followed by mood (cases mean score 22.3 vs 
controls 63.0, 0–100 scale)
Not specifically reported
Henry et al.37 Understand lived experience of disfigurement in HNC and explore 
what patients considered to be its influences
Main theme of a ‘ruptured self-image – a discontinuity in one’s sense of self’ (‘I am no longer 
the same person’)
Oscillation between this and search for normality to help reach acceptance
Involves functional and lifestyle changes, existential components (living with a life-
threatening disease) and has social implications
Selection bias – those who were comfortable speaking about 
topic, who were selected by healthcare professional; only those 
in urban hospital setting
Lal et al.42 Evaluate range of symptoms, other needs and evaluation of 
treatment strategies, especially for pain management
53/153 (35%) patients perceived (by oncologist assessment) to have some level of 
depression
32/63 (46%) NOK perceived patient had a ‘peaceful’ death (low symptom burden, low level 
of psychological distress)
Retrospective nature
Ledeboer et al.43 Evaluate experience of GPs in the care of palliative HNC patients, 
experiences of communication and consultation of attending 
specialists
25/41 (61%) GPs perceived their patients had sufficient psychosocial care with 5% perceiving 
it as insufficient
Retrospective nature
Ledeboer et al.44 Increase knowledge of how treatment and support are experienced 
by relatives of palliative HNC patients during the palliative stage and 
after death
From 45 relatives, 67% reported the patients were ‘sometimes’ or ‘often’ depressed; 69% 
perceived patients needed better psychosocial support during palliative stage
Only 23% relatives reported there was spiritual support
Relatives feedback may not reflect actual patients’ perspective; 
time between death and questionnaire completion was a year; 
didn’t explore all head and neck specific issues
Lidstone et al.45 Assess prevalence and severity of symptoms and concerns – identify 
patient groups who might benefit from routine SPC involvement in 
outpatient clinics
From the 60 HNC patients, 31 (52%) had concerns about the future; 35 (58%) felt tense/
worried/fearful; 34 (57%) felt low in mood/depressed
Not specifically reported
Lokker et al.8 Determine prevalence and impact of symptoms on daily functioning 
in HNC patients during palliative phase
Examine discrepancies between patients and family members 
symptom scoring
HNC patients had an average of 4 psycho-social symptoms
The most frequently reported psycho-social symptoms were ‘worrying’ (61%), ‘sadness’ 
(57%), ‘tenseness’ (52%), ‘depressed mood’ (52%), ‘powerlessness’ (50%).
Perceptions about the symptom impact on daily functioning differed between patients and 
family caregivers for ‘anxiety’, ‘expressing oneself’ and ‘powerlessness’
Didn’t use validated questionnaires
44% non-response rate
Limited numbers
Offerman et al.51 Evaluate interventions/impact of newly established ‘Expert Center’ on 
palliative HNC patients as perceived by bereaved relatives
After establishing an ‘Expert Centre’ for HNC care, bereaved relatives perceived improved 
psychosocial support offered (68% vs 51% satisfied with Head and Neck Department)
Retrospective design
Can’t be certain improvements purely relate to Expert Centre 
Feedback from relatives subjective
O’Sullivan and 
Higginson52
Explore Irish HNC patient and care-givers views on EoL care Participants very willing to discuss most aspects of EoL care (preferences for place of care 
and death, prognostication) with no signs of psychological distress
Concerns about family carer burden perceived as a potential barrier to dying at home
Some patients were in remission so views may alter as disease 
progresses
Patil et al.53 Identify the incidence of distress in HNC patients who are starting 
palliative chemotherapy and the factors associated with it
From 200 HNC patients, over 50% reported depression, fears, nervousness, sadness, worries
Baseline median distress score 3/10; 89 (44.5%) had high distress ⩾4/10; 88 underwent 
clinician counselling – 52 (59.1%) had a reduction in distress score to <4
Single centre study; post-hoc analysis
Roscoe et al.56 Understand ways in which end-stage HNC patients and their 
oncologists talk about end-of-life issues
Patients average depression scores were low (2.29, SD = 2.61) as were ratings of sadness 
(2.64, SD = 2.62) (measured on 10-point scale where 0 = never/not at all and 10 = very 
depressed or sad all the time)
Small numbers (n = 14); patients only asked on one occasion
Schuman et al.58 Determine perceived quality of care for HNC patients at the end of 
their lives
Perceptions by 58 bereaved relatives (from 286) deemed mean score for ‘emotional and 
spiritual support’ = 70/100
Mean score for ‘well-being and dignity’ = 69/100
Poor response rate
Retrospective nature
Different environment for using validated tool
Psychosocial and spiritual well-being specifically in last 1–2 weeks of life
Ethunandan et al.31 Evaluate quality of dying experience by examining symptoms in the 
last week of life
In the last week of life, 14/32 (44%) patients exhibited restlessness and confusion Retrospective nature
Fullarton et al.33 Record characteristics, mode of death and potential indicators of the 
quality of care at the end of life for HNC patients
In last week of life, 15/76 (20%) patients were agitated Retrospective nature
Missing data
Heterogeneous group
Limited number of hospice patients
Sesterhenn et al.59 Describe end-stage disease in advanced HNC patients – circumstances 
of final period of life and describe period in hospice setting
Wide range of different mental statuses described by healthcare team about the 16 patients 
– including ‘desperation’, suicidal episodes, confusion and agitation.
Not specifically reported











Table 4. Medical interventions with advanced head and neck cancer patients in the last 12 months of life.
Study Aim Main findings Reported limitations
Alsirafy 
et al.21
Determine prevalence of hypercalcaemia in advanced HNC 
patients in a palliative care setting
Assess impact of hypercalcaemia on administrative data that 
may indicate poorer EoL care
Hypercalcaemic patients more likely to be referred to palliative care, while they were inpatients 
(p = 0.004) compared with non-hypercalcaemic patients
During the last 3 months of follow-up, hypercalcaemic patients more likely to be hospitalised for 
⩾14 days (p = 0.01) and visit emergency room more than once (p = 0.04)
Not specifically reported
Chang et al.25 Investigated relationship between demographics, 
primary physician’s specialty, hospital characteristic and 
‘aggressiveness’ of their EoL care for oral cancer patients
Six indicators of ‘aggressiveness’ of EoL care in the last month of life: use of chemotherapy; >1 ER 
visit; >1 hospital admission; >14 days hospitalisation; an ICU admission; death in acute care hospital
96% of 5386 deceased patients had at least one indicator – mainly ER visits and ICU admission




Lack of information about impact of 
hospitalisation/chemotherapy in reducing 
symptoms
Chen et al.26 Determine prevalence of CPR in Taiwanese cancer patients in 
the last month of life and association with patient and physical 
characteristics
12% of 17,040 HNC patients had CPR in last month of life; higher compared with rest of cancers 
(10.5%).
Observational study so potential confounders
Ethunandan 
et al.31
Evaluate quality of dying experience by examining symptoms 
in the last week of life
13/20 HNC patients who died in hospital had a DNR order in place; none underwent CPR or had an 
ICU admission
17/32 (53%) needed emergency admissions in last month of life – most commonly due to bleeding; 




Record characteristics, mode of death and potential indicators 
of the quality of care at the end of life for HNC patients
Main reasons for last admission to surgical ward prior to death were: for operation, airway 




Limited number of hospice patients
Heinonen 
et al.35
Describe current status of palliative care of HNC patients in 
one specific university hospital region
Median survival 11 months; during this time, 37/60 patients (66%) attended emergency department 
⩾1x (range 0–6); 21 (35%) were hospitalised (most common reason was infection)
12/34 (35%) who were referred to the specialised palliative home care died at home versus 3/36 
(12%) of those who weren’t supported
Small numbers
Retrospective nature
Symptoms not systematically reported
Henson 
et al.37
Identify socio-demographic and clinical factors associated with 
end-of-life emergency department (ED) visits
Multiple ED visits in last month of life associated with diagnosis of lung or HNC (AOR 1.67, 95% CI 
1.4–2.0)
Issues relating to routinely collected data for 
example, quality of data coding
Ledeboer 
et al.44
Increase knowledge of how treatment and support are 
experienced by relatives of palliative HNC patients during the 
palliative stage and after death
10/20 responses from relatives perceived the medical treatment as ‘too intrusive’ for the patient Relatives feedback may not reflect actual 
patients’ perspective; time between death 
and questionnaire completion was a year; 
didn’t explore all head and neck specific issues
Mercandante 
et al.49
Assess patient characteristics who were hospitalised in last 
days of life after being assisted by a home palliative care team
Identify possible risk factors for hospitalisation
138/550 (25.1%) admitted to hospital, of which 20 had HNC
Logistic regression analysis showed patients with HNC (OR 2.62, 95% CI 1.24–5.54, p = 0.01) and lung 
cancer more likely to die in hospital (but very small numbers)
Single centre – results not generalisable
Offerman 
et al.51
Evaluate interventions/impact of newly established ‘Expert 
Center’ on palliative HNC patients as perceived by bereaved 
relatives
Relatives perceived a reduction in satisfaction with medical treatment (77% vs 81%) and poorer 
perceptions about whether HNC department did ‘everything to make life for the patient as 
comfortable as possible’ (64% vs 75%)
13% relatives perceived the patient had treatment against their wishes





Explore Irish HNC patient and care-givers views on EoL care Patients found it challenging to discuss preferred focus of care and ACP
All tended to favour maximum medical interventions associating palliative care with ‘giving up’ or 
‘losing the fight’
Whereas family carers perceived quality of life should have more priority compared with quantity of life
Some patients were in remission so views may 
alter as disease progresses
Randen 
et al.55
Describe how palliative chemotherapy is prescribed at the 
end-of-life to patients
15/25 (60%) HNC patients had chemotherapy





Determine perceived quality of care for HNC patients at the 
end of their lives
SPC team involvement improved perceptions of care at the time of death (p < 0.001)
Palliative anti-cancer treatments (radiotherapy ± chemotherapy) improved perceptions about 
managing symptoms and care at the time of death (p = 0.011, p = 0.017).
Poor response rate
Retrospective nature
Different environment for using validated tool
Ullgren 
et al.64
Describe HNC patients referred to palliative care and how care 
transition from acute oncological to palliative care impacted 
on Health Related Quality of Life (HRQoL) and information
Explore HNC patients' HRQoL and perceived information
43/202 (21%) HNC patients were referred to palliative care
Palliative care group reported more frequent ER attendance compared with group without palliative 
care (18/43, 43% vs 22/114, 19%)
Small proportion referred to PC
Didn’t use HNC specific instruments
ACP: advance care planning; AOR: adjusted odds ratio; CI: confidence intervals; CPR: cardio-pulmonary resuscitation; DNR: do not resuscitate; EoL: end-of-life; ER: emergency room; HNC: head and neck cancer; ICU: intensive care 


















Table 5. Communication and decision-making issues in advanced head and neck cancer patients.
Study Aim Main findings Reported limitations
Practical difficulties with communication
Alt-Epping 
et al.22
Assess symptoms and psychosocial needs of patients with incurable HNC (at 
time of diagnosing incurability)
5/22 HNC patients depended on tracheostomy
Had practical implications for conducting study – communication by telephone (e.g. for making appointments) not 
possible and needed face-to-face communication
Small numbers
Questionnaires not fully understood by 
participants
Forbes32 Outline nature, incidence and management of problems and the role of the 
hospice in the patients care
From 38 HNC patients, 20 (53%) reported communication as an issue
Four patients could only communicate by writing
Not specifically reported
Lidstone et al.45 Assess prevalence and severity of symptoms and concerns – identify patient 
groups who might benefit from routine SPC involvement in outpatient clinics
From 460 patients, the 60 HNC patients reported the highest prevalence of problems with communication (30%) 
compared with other cancer groups
Not specifically reported
Lin et al.46 Describe symptom patterns of terminal HNC patients in palliative care unit Statistically significant association of communication difficulties with presence of a tracheostomy (p < 0.001) Not specifically reported
Sesterhenn 
et al.59
Describe end-stage disease in advanced HNC patients – circumstances of 
final period of life and describe period in hospice setting
Communication difficult for most patients (due to tracheostomy, respiratory secretions or tumour obstruction); only 
4/16 able to talk regularly and most had tracheostomy
Not specifically reported
Information provision and decision-making
Chiu et al28 Identify most frequently encountered ethical dilemmas in the palliative 
care unit
HNC patients had more ethical dilemmas – 1.75/patient compared with other cancer sites (except gastric cancer)
Dilemmas about place of care occurred most frequently with HNC patients (43.8%)
Other frequent HNC patient dilemmas included problems accepting/complying with recommended discharge plans and 
dilemmas about hydration and nutrition
Not specifically reported
Dronkers et al.29 Investigate whether prognostic information on life expectancy is included 
during communication on diagnosis and treatment plans between physicians 
and HNC patients in all phases of illness
20/23 HNC patients received a curative treatment plan (n = 3, 13% palliative)
Primary initiators of prognosis discussion – HNC surgeons 58%, patients 18%, caregivers 24%
In 7 interviews, prognosis provided in quantitative manner that is, numerical probability estimates (13 quotations, 5.9%)
In all 23 consultations, prognosis provided in a qualitative manner, that is, using words ‘most likely’ or highly 
improbable’ (n = 209, 94.1%)
Two main communicative styles:
Directive – including paternalistic language, use of medical jargon
Affective – including patient-empowering professional attitude, giving hope, but also use of euphemisms
Bias due to patient participants being more 
engaged in this topic and physicians being 
aware their discussions are recorded
Ledeboer et al.43 Evaluate experience of GPs in the care of palliative HNC patients, 
experiences of communication and consultation of attending specialists
From 41 GPs, 33% weren’t informed by the hospital team the HNC was incurable
Provision of information rated as 6.4 (on 0–10 point rating scale)
Better communication associated with increased GP satisfaction with allocation of responsibilities (p < 0.01)
54% GPs perceived information provided to patients was adequate; a fifth perceived important gaps
Retrospective nature
Ledeboer et a.44 Increase knowledge of how treatment and support are experienced by 
relatives of palliative HNC patients during the palliative stage and after 
death
33 (75%) relatives perceived the understandability of the information about the medical condition as ‘good’ or ‘very 
good’
Relatives feedback may not reflect actual 
patients’ perspective; time between death and 
questionnaire completion was a year; didn’t 
explore all head and neck specific issues
Offerman et al.51 Evaluate interventions/impact of newly established ‘Expert Center’ on 
palliative HNC patients as perceived by bereaved relatives
After establishing an ‘Expert Centre’ for HNC care, bereaved relatives’ perceived improved satisfaction about level of 
communication with surgeon (78% vs 59% perceived it as ‘good’ or ‘very good’)
Retrospective design
Can’t be certain improvements purely relate 




Explore Irish HNC patient and care-givers views on EoL care In terms of communication/information, patients were divided between ‘full disclosure’ and a more ‘passive approach’
Family carers favoured being fully informed to help them prepare and cope
Some patients were in remission so views may 
alter as disease progresses
Roscoe et al.56 Understand ways in which end-stage HNC patients and their oncologists talk 
about end-of-life issues
Patients’ mean score on general communication subscale from ‘Quality Of Communication’ (QOC) questionnaire was 
8.47 (SD = 1.80) (10-point scale)
Mean score on EoL subscale was 7.39 (SD = 2.82) indicating relatively high ratings
Patients, however, reported an absence of communication about key end-of-life topics; evidence of patients’ 
misunderstanding or misinterpreting information provided
Small numbers (n = 14); patients only asked on 
one occasion
Schuman et al.58 Determine perceived quality of care for HNC patients at the end of their 
lives
Mean score for ‘information and communication’ was 61/100 (SD 32.05)
52/60 (90%) patients had advanced directives and 44 (76%) had DNR orders
Poor response rate
Retrospective nature
Different environment for using validated tool
Ullgren et al.64 Describe HNC patients referred to palliative care and how care transition 
from acute oncological to palliative care impacted on Health Related Quality 
of Life (HRQoL) and information
Explore HNC patients' HRQoL and perceived information
From 289 patients, those referred to palliative care (n = 43) had lower levels of perceived information about causes of 
disease (p < 0.000) and extent/spread of disease (p < 0.001) compared with those without palliative care referral
Small proportion referred to palliative care
Didn’t use HNC specific instruments
Xuereb et al.65 Explore local decision-making, from an ethical point of view, about HNC Ten participants asked whether it was ethical to withhold treatment for low prognosis HNC patients (and only offer 
palliative treatment) – 3 agreed to withhold treatment and 7 considered this decision unethical (but emphasised 
informed consent should always take priority)
8/10 participants agreed patients form an important part in the decision-making process
Factors influencing level of patient engagement include intellect; co-morbidities; uncertainties about tolerance and 
outcome of treatment; avoiding false expectations
Not specifically reported












Table 6. Place of death for advanced head and neck cancer patients.
Study Aim Main findings Reported limitations
Chen et al.27 Determine impact of patient 
demographics, disease characteristics, 
prognosis awareness and support network 
variables on preference for home death
More than half of 2881 participants expressed preference 
to die at home (n = 1,114, 54.7%)
Having HNC was a factor significantly associated with 
preference to die at home (AOR = 1.57, 95% CI [1.10, 2.24], 
p = 0.012)
Convenience sample limiting 
generalisability
Didn’t specifically look at hospice 
deaths (just home vs not home)
Fullarton et al.33 Record characteristics, mode of death and 
potential indicators of the quality of care 
at the end of life for HNC patients
From the 76 HNC patients, those dying in the hospice were 
younger compared with those who died in the hospital 




Limited number of hospice patients
Kuo et al.40 Assess end-of-life care for patients with 
HNCs in Taiwan
From 98,221 HNC patients, those who were male, lived 
in more urbanised areas, had a higher family income, 
received hospice care in last month of life, had been 
prescribed opioids in last 3 months of disease were more 
likely to die at home or in hospice wards
Those who received chemotherapy, surgery or 
radiotherapy in last month of life tended to die during 
acute in-hospital admission (and total medical costs were 
higher)
Retrospective data analysis
Unable to explore reasoning for 
decision-making
Lock and Higginson47 Describe the older population who die of 
cancer and the factors which may affect 
place of death
From 315,462 cancer deaths, hospice death was most 
common among those dying of HNC (19%)
Data completeness
Cross-sectional study so unable to 
control for potential confounders
Shah et al.60 Estimate frequency of referral of HNC 
patients to ‘terminal care’
Ascertain where and when the patient 
died
Place of death identified for 51 HNC patients (from 74) – 




No details about specifics of 
palliative care/hospice care 
received
AOR: adjusted odd ratio; HNC: head and neck cancer.
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varied.8,21,33,44,52,55 In the two larger studies (with more 
than 100 patients), more than 50% expressed psycho-
logical symptoms such as ‘worrying’, ‘fears’, ‘sadness’, or 
‘depressed mood’.8,52 Being a burden on family carers 
was one specific concern raised.51 Within a further 
study, over a third (35%) of people with head and neck 
cancer were perceived to have some level of depression 
by their oncologist.41 Psychological symptoms manifest-
ing as agitation or confusion were also reported during 
the final weeks prior to death.28,32,58
In terms of psychosocial support and care, one study 
reported that 25/40 (61%) of General Practitioners per-
ceived their patients had received sufficient care.42 
Perceptions from family carers varied. In one study, the 
‘emotional and spiritual’ support was rated more highly 
(and hence needs better met) compared with manage-
ment of physical symptoms.57 In another, however, 
almost 70% bereaved relatives perceived improved psy-
chosocial support was needed during the palliative phase 
of illness,43 which led to the development of an ‘Expert 
Centre’ to help address these unmet needs.50
No study specifically focused on spiritual well-being. 
One qualitative study explored the ‘lived experience’ of 
having disfigurement and described the subsequent 
existential impact.35 A further study reported only 
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No data on advanced HNC* n=17
Not focused on needs/experiences n=38
Had no empirical data n=32
Not focused on HNC* n=30
*HNC = head and neck cancer
Records idenfied through
other sources (n=2)
Figure 1. Flow diagram for the scoping review process.2
Mayland et al. 13
support for head and neck cancer patients had been 
provided.43
Medical interventions in the last 12 months 
of life
Fourteen studies had a focus on medical interventions 
(Table 4). Generally, having head and neck cancer was 
associated with a high prevalence of ‘intensive’ inter-
ventions, especially in the last month of life. These 
interventions included emergency department attend-
ance, cardio-pulmonary resuscitation, hospital admis-
sions, intensive care admissions and ongoing 
chemotherapy.25,26,31,35,37,55,64 Factors associated with 
hospital admission included the presence of hypercalcaemia,21 
respiratory or airway management issues,31,33 infection35 
and problems relating to bleeding, pain and swallowing 
difficulties.31 Hospital admission could still occur fre-
quently even when palliative care teams were involved.64 
Two retrospective studies, conducted after death, reported 
that having head and neck cancer was associated with a 
greater risk of dying in hospital,25,49 although one study 
had very small numbers.49
Differing views were reported about the appropriate-
ness of interventions. Patients could favour maximum 
medical interventions52 and bereaved relatives perceived 
the palliative anti-cancer treatments improved symptom 
management.58 On the other hand, however, bereaved 
relatives reported that treatments had been ‘too intru-
sive’ or not in keeping with the patients’ wishes.44,51
Communication and decision-making
Fifteen papers including a focus on communication and deci-
sion-making for head and neck cancer patients (Table 5). Five 
papers focused more on the prevalence of the practical 
difficulties and issues relating to poor speech.12,32,45,46,59 
Issues relating to communication were more common 
compared with other cancers,45 especially if the patient 
had a tracheostomy.22,46,59
Ten of the papers focused on communicating informa-
tion and decision-making.28,29,43,44,51,52,56,58,64,65 An inter-
view study of medical professionals in Malta, explored 
ethical factors influencing decision-making about treat-
ment. The majority who were interviewed (7/10) per-
ceived the need to provide full treatment for people with 
head and neck cancer, even if the prognosis was poor. 
Most agreed, however, that the patient formed an impor-
tant part in the decision-making process.65 In a study 
assessing the communication of prognosis between 
healthcare professionals and patients, different ways 
were recognised. These included the use of numerical 
probability estimates, qualitative language or a combina-
tion of both.29 Although perceptions by patients and/or 
family members about the quality of communication 
could be good,44,51,57,58 there were reports of patients mis-
understanding or misinterpreting information.56 One 
study described poorer levels of understanding about 
their illness when patients were known to palliative care 
teams.64 Within another qualitative study, dissonance 
between patient and family members’ information prefer-
ences was described. Patients varied between wishing for 
‘full disclosure’ and a more ‘passive approach’ whereas 
family carers favoured being fully informed.52 Further 
communication and decision-making challenges included 
the information transfer between different healthcare 
teams43 and the ethical complexities that can arise relat-
ing to hydration and nutrition.28
Place of death 
Five studies focused on place of death, of which two were 
population-based40,47 and three were smaller cohort stud-
ies (two having less than 100 patients) (Table 6).27,33,60 
From the population-based studies, a Taiwanese study 
reported over 70% head and neck cancer patients died in 
the acute hospital.40 By contrast, the other study, con-
ducted within the UK, suggested that head and neck can-
cer was associated with an increased likelihood of dying in 
a hospice compared with other cancers.47
Discussion
Summary of main findings
Compared with other cancers, this scoping review con-
firms head and neck cancer patients often have complex 
palliative care needs, especially if there is a high degree of 
symptom burden. Variability in the timing and access to 
palliative care services, however, is recognised. Dissonance 
seen between patients and family carers, specifically 
about information needs and decision-making, are addi-
tional recognised complexities. A high prevalence of inter-
ventions such as emergency department attendance and 
hospital admissions occur for patients with advanced 
head and neck cancer even during the last weeks of life. 
Sole engagement with palliative care services does not 
necessarily negate this.
Research in this area has tended to be via single centre, 
quantitative studies. Few qualitative studies have been 
conducted with advanced head and neck cancer patients 
and none have focused purely on the spiritual well-being 
of head and neck cancer patients. There were no inter-
ventional studies identified.
What this study adds and implications for 
practice and research
The key questions facing palliative care services surround 
the identification of who is in greatest need of referral, 
how these individuals should be identified, and what 
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model of care should be provided.66 These questions are 
particularly pertinent for head and neck cancer patients 
who undoubtedly have palliative care needs, but for 
whom the method of identification and the optimum 
model of care provision is less clear. Our review shows 
variability in access to palliative care services with some 
patients receiving referrals late and certain groups, such 
as older, white, female patients, more likely to be referred.
In view of the ‘scarcity of palliative care resources,66 
there are a number of potential ways to help identify 
which head and neck cancer patients would most benefit 
from palliative care input. Specific ‘triggers’ are recog-
nised to help prompt palliative care consults in the emer-
gency department, in-patient wards67 and from oncology 
services.68 These are generic tools aimed to screen a large 
population, however, rather than having been specifically 
validated within the head and neck cancer remit. More 
individualised ways to help illustrate patients concerns 
include the use of Holistic Needs Assessment (HNA) 
tools,69 and Patient Reported Outcome Measures, of 
which a vast array have been used within head and neck 
cancer.70 The Patient Concerns Inventory (PCI) is an item-
prompt list specifically used to guide head and neck can-
cer clinical consultations including wider multi-professional 
engagement. Although extensively used globally, its focus 
of use has been with curative head and neck cancer 
patients, but it has potential to be adapted.71 Further 
research into which ‘screening’ tool or method would be 
most appropriate for initiating palliative care referral for 
head and neck cancer patients seems pertinent. 
Furthermore, clarity about how best to incorporate spe-
cific staging indicators for those recognised to be 
‘high risk’72 in additional to individual patient needs would 
seem beneficial.
As well as establishing equitable referral methods, 
defining an appropriate model of integrated care is 
needed. This poses a further challenge for advanced head 
and neck cancer patients. Our review indicated there was 
a high level of interventions needed and a reliance on 
hospital-based care even during the last weeks of life. This 
finding may relate to issues arising from the use of feeding 
tubes and tracheostomies to help sustain vital function-
ing, and the fact that hospital admissions were commonly 
related to breathing or airway difficulties. Issues such as 
these can be challenging to manage in a community set-
ting. More widely, ‘treatment related incidents’ such as 
those relating to other interventions, for example, urinary 
catheters or nasogastric tubes, are a recognised factor 
prompting patient safety incidents during ‘out-of-hours’ 
care.72 Additionally, obtaining timely access to care can be 
a challenge.72 Solely relying on engagement with palliative 
care services is not sufficient to alleviate these issues.64 
Instead, the focus may be needed within a number of 
areas. Firstly, there is a need to increase integration and 
co-ordination between different multi-disciplinary teams 
to avoid ‘silo’ working patterns.64 Additionally, enhanced 
collaboration between teams73 would potentially help 
ensure timely access to specialist knowledge is more 
readily available. Finally, ways to help upskill healthcare 
professionals supporting patients within the community, 
and specific training about the management of tracheoto-
mies and feeding tubes may help alleviate the need for 
hospital care.
Another important finding from this study was the dis-
sonance between patient and family carer views about 
information needs and decision-making. Generally, 
unmet informational needs are recognised within 
advanced cancer as a whole,15 as well as earlier in the 
head and neck cancer disease trajectory.74 Additional 
complexities arise due to the many issues surrounding 
communication, that is inability to directly verbalise and 
uncertainty about the best way to communicate progno-
sis. Furthermore, the discussions about goals of care and 
the optimal ways to consider patient preferences are 
especially challenging in advanced disease as the treat-
ment can be intensive and the outcomes uncertain.16 
One national cohort study identified that 10% of people 
with head and neck cancer initially treated with ‘curative’ 
intent died within the first 12 months following diagnosis.75 
Initiatives such as the ‘Making good decisions in collabo-
ration’ (MAGIC) improvement programmes have been 
tested in early cancers involving the head and neck.76 An 
‘Option Grids’ approach, which involves using easy-to-
read decision aids with patients and healthcare profes-
sionals comparing treatment options, has also been 
assessed in the head and neck cancer context.77 Future 
research could focus on ways to engage advanced head 
and neck cancer patients and family carers more fully in 
shared decision-making needs, being mindful of the 
appropriate timing, differing information needs and the 
cultural sensitivity of these discussions.
In terms of research methodology, the majority of 
studies were quantitative observational studies con-
ducted within single institutions. There were no inter-
ventional studies and there was only one mixed methods 
study, despite the unique benefits this approach can 
bring.78 Additionally, only one study explored the spirit-
ual or existential impact of the illness. There is a real 
need to develop prospective multi-centre studies, using 
both quantitative and qualitative approaches. As well as 
gaining a greater understanding of needs and experi-
ences, testing specific components of models of care 
would be beneficial. A broader approach to assessing 
holistic care, including the spiritual component, would 
also be important.
Strengths and limitations
This scoping review followed an established systematic 
method and examined a breadth of different experiences 
Mayland et al. 15
and needs for a particularly complex subgroup of cancer 
patients. Our search included studies from a diverse range 
of countries and cultures and hence has wide-ranging 
relevance.
There were, however, limitations to this review. We 
did not conduct hand searching of key journals and grey 
literature was not included. Our definition of ‘advanced 
cancer’ was qualitatively defined rather than using spe-
cific disease staging criteria and we did not conduct 
additional searches using ‘place of death’ as a key search 
term. Additionally, we only included English language 
publications. In view of all these factors, some sources of 
data may have been overlooked. We did not focus on 
family carer needs per se but accept that this is an impor-
tant area and would represent a focus for future study. 
Finally, we did not include a quality appraisal of all 
included studies, as within the remit of scoping reviews, 
risk of bias/quality appraisal is not generally 
recommended.17
Conclusion
This scoping review has demonstrated the complexity of 
care for people with advanced head and neck cancer and 
that there are issues related to the current healthcare sys-
tems. Specific focus is needed about the optimum way 
those in greatest need should be identified and referred 
to palliative care services. Additionally, further clarity and 
assessment about the particular model of integrated care 
is required, which can address the diverse symptom 
needs, the communication needed to further inform deci-
sion-making, and the frequent use of interventions and 
issues that can arise ‘out-of-hours’ relating to these. 
Linkage between research and service design delivery 
across teams, disciplines and care settings seems key for 
future success.
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